Related references
Note: Only part of the references are listed.Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review
Roy O. Mathew et al.
KIDNEY INTERNATIONAL (2017)
Ethnic Difference in Proximal Aortic Stiffness An Observation From the Dallas Heart Study
Akshay Goel et al.
JACC-CARDIOVASCULAR IMAGING (2017)
Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes
L. Parker Gregg et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Protein-Bound Uremic Toxins from Gut Microbiota and Inflammatory Markers in Chronic Kidney Disease
Natalia A. Borges et al.
JOURNAL OF RENAL NUTRITION (2016)
Serum Levels of Monocyte Chemoattractant Protein-1 and All-Cause and Cardiovascular Mortality among Patients with Coronary Artery Disease
Ding Ding et al.
PLOS ONE (2015)
Usefulness of a Combination of Monocyte Chemoattractant Protein-1, Galectin-3, and N-Terminal Probrain Natriuretic Peptide to Predict Cardiovascular Events in Patients With Coronary Artery Disease
Jose Tunon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study
Angels Betriu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study
Mariana Murea et al.
BMC NEPHROLOGY (2012)
Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease - a cross-sectional study of predialysis, dialysis and kidney-transplantation patients
Alejandro Recio-Mayoral et al.
ATHEROSCLEROSIS (2011)
High White Blood Cell Count and Low Estimated Glomerular Filtration Rate Are Independently Associated With Serum Level of Monocyte Chemoattractant Protein-1 in a General Population
Ako Fukami et al.
CLINICAL CARDIOLOGY (2011)
Serum C-Reactive Protein Levels and Death and Cardiovascular Events in Mild to Moderate Chronic Kidney Disease
Yorihiko Koeda et al.
INTERNATIONAL HEART JOURNAL (2011)
Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
Lorien S. Dalrymple et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Inflammation, kidney function and albuminuria in the Framingham Offspring cohort
Ashish Upadhyay et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Executive Summary: Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association
Donald Lloyd-Jones et al.
CIRCULATION (2010)
Indoxyl Sulfate Stimulates Monocyte Chemoattractant Protein-1 Expression in Human Umbilical Vein Endothelial Cells by Inducing Oxidative Stress Through Activation of the NADPH Oxidase-Nuclear Factor-κB Pathway
Natsumi Masai et al.
CIRCULATION JOURNAL (2010)
Association Between Plasma Monocyte Chemoattractant Protein-1 Concentration and Cardiovascular Disease Mortality in Middle-Aged Diabetic and Nondiabetic Individuals
Lorenzo Piemonti et al.
DIABETES CARE (2009)
Increased Plasma and Endothelial Cell Expression of Chemokines and Adhesion Molecules in Chronic Kidney Disease
A. E. M. Stinghen et al.
NEPHRON CLINICAL PRACTICE (2009)
Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort
U. Baber et al.
KIDNEY INTERNATIONAL (2008)
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes
James A. de Lemos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Left ventricular hypertrophy is more prevalent in blacks than whites in the general population - The Dallas Heart Study
MH Drazner et al.
HYPERTENSION (2005)
Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study
H Kramer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis - Assessment in chronic hemodialysis patients
KF Kusano et al.
CIRCULATION JOURNAL (2004)
The Dallas Heart Study: A population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health
RG Victor et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis
R Deo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Fasting plasma leptin, tumor necrosis factor-α receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women -: Impact on cardiovascular mortality
L Piemonti et al.
DIABETES CARE (2003)
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes
JA de Lemos et al.
CIRCULATION (2003)
Multi-ethnic study of atherosclerosis: Objectives and design
DE Bild et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes
F Chiarelli et al.
DIABETES CARE (2002)
Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events
A Papayianni et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients:: association,vith malnutrition, inflammation, and cardiovascular disease
P Stenvinkel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Share Paper
